当前位置:首页 - 行情中心 - 广康生化(300804) - 财务分析 - 现金流量表

广康生化

(300804)

  

流通市值:10.62亿  总市值:28.59亿
流通股本:2750.00万   总股本:7400.00万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金409,296,882.92271,338,320.55122,442,334.38465,064,092.93
  收到的税费返还21,225,086.6916,909,280.2510,596,744.3430,941,428.41
  收到其他与经营活动有关的现金2,567,108.51880,302.93239,375.9838,128,345.99
  经营活动现金流入小计433,089,078.12289,127,903.73133,278,454.7534,133,867.33
  购买商品、接受劳务支付的现金263,239,333.7171,269,694.3283,909,341.71366,848,533.19
  支付给职工以及为职工支付的现金80,333,476.7253,832,213.5529,521,732.3595,811,611.78
  支付的各项税费6,947,864.972,808,984.621,192,590.783,208,182.35
  支付其他与经营活动有关的现金41,283,247.5522,543,672.2114,430,633.5653,920,701.48
  经营活动现金流出小计391,803,922.94250,454,564.7129,054,298.4519,789,028.8
  经营活动产生的现金流量净额41,285,155.1838,673,339.034,224,156.314,344,838.53
二、投资活动产生的现金流量:
  收回投资收到的现金2,172,000,0001,757,000,000956,002,077.552,363,000,000
  取得投资收益收到的现金5,787,239.234,005,471.52,145,048.386,082,188.8
  处置子公司及其他营业单位收到的现金净额---4,343,144.58
  投资活动现金流入小计2,177,787,239.231,761,005,471.5958,147,125.932,373,425,333.38
  购建固定资产、无形资产和其他长期资产支付的现金159,434,628.3480,687,138.4536,980,208.3895,661,295.07
  投资支付的现金1,872,000,0001,717,000,000978,000,0002,608,000,000
  投资活动现金流出小计2,031,434,628.341,797,687,138.451,014,980,208.382,703,661,295.07
  投资活动产生的现金流量净额146,352,610.89-36,681,666.95-56,833,082.45-330,235,961.69
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0-1,500,000
  取得借款收到的现金297,438,945.18190,156,764.01125,909,061.71312,395,941.71
  收到其他与筹资活动有关的现金29,862,433.5917,354,930.4510,387,566.3457,076,875.51
  筹资活动现金流入小计327,301,378.77207,511,694.46136,296,628.05370,972,817.22
  偿还债务支付的现金137,713,921.595,392,621.4759,192,976.49237,771,705.42
  分配股利、利润或偿付利息支付的现金7,998,290.45,509,877.952,859,044.958,139,271.87
  支付其他与筹资活动有关的现金41,713,710.9126,051,669.0512,285,345.9938,097,784.49
  筹资活动现金流出小计187,425,922.81126,954,168.4774,337,367.43284,008,761.78
  筹资活动产生的现金流量净额139,875,455.9680,557,525.9961,959,260.6286,964,055.44
四、汇率变动对现金及现金等价物的影响1,389,431.871,208,425.611,055,984.992,381,932.87
五、现金及现金等价物净增加额328,902,653.983,757,623.6810,406,319.46-226,545,134.85
  加:期初现金及现金等价物余额122,488,135.19122,488,135.19122,488,135.19348,260,802.66
  期末现金及现金等价物余额451,390,789.09206,245,758.87132,894,454.65121,715,667.81
补充资料:
  净利润-29,069,021.73-34,245,609.5
  资产减值准备-461,953.88-3,875,050.24
  固定资产和投资性房地产折旧-32,142,116.03-58,674,510.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-32,142,116.03-58,674,510.83
  无形资产摊销-1,220,302.13-5,034,735.77
  长期待摊费用摊销-1,084,284.86-1,928,059.5
  处置固定资产、无形资产和其他长期资产的损失-15,128.49--
  固定资产报废损失-2,606,331.19-4,853,072.15
  公允价值变动损失----295,332.05
  财务费用-4,269,758.56-6,253,306.98
  投资损失--3,881,934.58--9,382,830.52
  递延所得税-429,042.29--6,481,479.81
  其中:递延所得税资产减少-771,600.36--5,724,685.27
    递延所得税负债增加--342,558.07--756,794.54
  存货的减少--42,977,853.24-8,480,560.33
  经营性应收项目的减少-12,057,673.48--140,205,487.31
  经营性应付项目的增加--958,104.6-46,106,964.68
  其他-2,580,858.39--
  现金的期末余额-206,245,758.87-121,715,667.81
  减:现金的期初余额-122,488,135.19-348,260,802.66
  现金及现金等价物的净增加额-83,757,623.68--226,545,134.85
公告日期2025-10-242025-08-222025-04-182025-04-18
审计意见(境内)标准无保留意见
TOP↑